AstraZeneca and University of Oxford are working on modification of the existing Covid-19 vaccine Covishield in India to become effective against the South African coronavirus.
AstraZeneca’s Austria country manager, Sarah Walters said in an interview that the vaccine is expected to be ready by the end of the year.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…